Return to News

COSMIC News

mut signatures.PNG

Mutational Signatures Update

15 May 2019

Somatic mutations are present in all cells of the human body and occur throughout life. They are the consequence of multiple mutational processes, including the intrinsic, slight infidelity of the DNA replication machinery, exogenous or endogenous mutagen exposures, enzymatic modification of DNA, and defective DNA repair. Different mutational processes generate unique combinations of mutation types, termed “Mutational Signatures”.

Earlier studies (Nik-Zainal S. et al., Cell (2012); Alexandrov L.B. et al., Cell Reports (2013); Alexandrov L.B. et al.,Nature (2013); Helleday T. et al., Nat Rev Genet (2014); Alexandrov L.B. and Stratton M.R., Curr Opin Genet Dev (2014)) identified 30 mutational signatures. These were curated to form a census of signatures and have been shown on the COSMIC website since 2015. We are pleased to announce a major expansion of the mutational signatures, based on the analysis of 84,729,690 somatic mutations from 4,645 whole cancer genome and 19,184 exome sequences encompassing most cancer types, we recently characterised 49 single base substitution, 11 doublet base substitution, four clustered base substitution, and 17 small insertion and deletion mutational signatures.

In this release of COSMIC mutational signatures, we provide a summary “vignette” for each mutational signature. The vignettes include mutational profiles and notes on potential aetiology, associated mutational signatures, how the signature has changed during iterations of analysis, and other pertinent comments. These are intended to be short, very high level, “aides-memoire” for key elements of what we know, suspect or has been widely discussed for each signature. They are not intended to be comprehensive summaries of everything reported in the scientific literature and they are not referenced. Further, we provide access to all input data and references for original sources that were used to derive these mutational signatures (Alexandrov L. et al. 2018).

The final sets of reference mutational signatures were determined from the ICGC/TCGA Pan Cancer Analysis of Whole Genomes (PCAWG) Network analysis, supplemented by additional signatures from the other datasets. Signatures were supported by the outcomes of analyses using the 192 and 1536 mutation classifications, the existence of individual cancer samples dominated by a particular signature, and, where available, prior experimental evidence for certain mutational signatures (full methods).

Each signature has been allocated a number consistent with, and extending, the previous COSMIC mutational signatures. Some previous signatures have been split into multiple constituent signatures and these were numbered as before but with additional letter suffixes (eg, signature SBS17 has been split into signatures SBS17a and SBS17b). DNA sequencing and analysis artefacts also generate mutational signatures, and we indicate which signatures are possible artefacts these have also been included.

mut sig diff.PNG

Both the expanded mutational signatures (v3) and the previous mutational signatures (v2) are available. Full details of this work are available in Alexandrov L. et al. 2018.

About

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the most comprehensive resource for exploring the impact of somatic mutations in human cancer. Here on our news page we aim to give you an insight into what we are doing and why. We will keep you updated with new developments and release information as well as any events we are hosting.

Tags

release

workshop

website

curation

COSMIC-3D

vacancies

downloads

user experience

data submission

website update

Cancer Gene Census

mutation ID

Hallmarks of Cancer

GRCh37

drug resistance

GRCh38

video

tutorial

birthday

International Women's Day

literature

mutational signatures

Mesothelioma

conference

AACR

gene

Bile duct cancer

cholangiocarcinoma

Europe PMC

Service announcement

blog

survey

updates

v90

search

cosv

updated

CDS

Fasta

cDNA

disease focus

world cancer day

new product

cmc

DIAS

Actionability

COSMIC

webinar

introduction to cosmic

mutations

celebrating success

Oncology

oncology trials

precision medicine

clinical trials

precision oncology

cancer

genomics

immuno oncology

breast cancer

cosmic v95

bioinformatics

cancermutationcensus

COSMICv95

Lung Cancer

Glioblastoma

testicular cancer

cancer prevention

biomarkers

Cancer Research

tumour microenvironment

copy number variants

ageing

genes

genome

clones

smoking

Clonal haematopoesis

tumour

inherited

disease

individuals

risk

variants

leukaemia

Myelodysplastic syndrome

lymphoma

haematological cancers

Myeoloproliferative neoplasms

myeloma

haematological

somatic mutations

blood cancers

blood cancer

NRAS

acral lentiginous melanoma

BRAF

melanoma

driver gene

skin cancer

uv light

Mexico

chromosome

acral melanoma

breed predisposition

genetics

PIK3CA

driver genes

canine cancer

data ecosystem

database

canine

tumour board

barrett's oesophagus

oesophageal cancer

upper gi

gene panel

cell lines project

Wellcome Sanger Institute

sanger

uv radiation

uv nail lamp

SBS18

reactive oxygen species

DNA damage

uv damage

sebaceous gland carcinoma

Kaposi cell carcinoma

Lynch syndorme

carcinoma

cancerresearch

Merkel cell carcinoma

Muir-torres syndrome

MLH1

sanger institute

Mike Stratton

cancer genome project

BRCA2

mutographs

resistance mutations

IWD24

Women in STEM

IT

computational biology

STEM career

computer science